Anxiety in pandemic epidemiological characteristics of anxiety disorders seen through telepsychiatry in a university hospital

Main Article Content

Julio Torales
Ariel Insaurralde
Carlos Ríos-González
Marcelo O´Higgins
Rodrigo Navarro
Nicolás Ayala-Servín
José Almirón-Santacruz
Alice Aquino-Arrúa
Hugo Balbuena-Monges
Fernando Guerra-Aquino
Isabela Ortega-Cano
Iván Barrios
João Mauricio Castaldelli Maia
Antonio Ventriglio
Noelia Ruíz Díaz

Abstract

Introduction: the COVID-19 pandemic has increased anxiety cases and caused big modifications in the way medical care is provided.
Objective: to describe the epidemiological characteristics of anxiety disorders treated through telepsychiatry in a Hospital Universitario.
Methodology: observational, descriptive, cross-sectional study. A non-random purposive sampling was performed. Electronic records of patients treated in the Servicio de Psiquiatría of the “Hospital de Clínicas”, Paraguay, between February and May 2021 were used. Descriptive statistics were performed for all variables. Measures of central tendency and dispersion were calculated for quantitative variables. Qualitative variables were summarized in frequencies and percentages.
Results: the analysis included 804 patients. Out of the patients, 71,5 % (575) were from rural areas. Out of all patients diagnosed with an anxiety disorder (20,49 % n = 165), 69,1 % (114) were female and 49,7 % (82) had panic disorder (episodic paroxysmal anxiety), 28,5 % (47) were diagnosed with generalized anxiety disorder, and 21,8 % (36) had an unspecified anxiety disorder.
Conclusion: more than 20 % of the patients who consulted through the telepsychiatry modality presented with an anxiety spectrum disorder. Cases were presented in both rural and urban areas and preferably in females. Panic disorder emerged as the most frequent disorder in the accessible population, representing almost half of all diagnosed anxiety cases.

Article Details

How to Cite
1.
Torales J, Insaurralde A, Ríos-González C, O´Higgins M, Navarro R, Ayala-Servín N, Almirón-Santacruz J, Aquino-Arrúa A, Balbuena-Monges H, Guerra-Aquino F, Ortega-Cano I, Barrios I, Castaldelli Maia JM, Ventriglio A, Ruíz Díaz N. Anxiety in pandemic: epidemiological characteristics of anxiety disorders seen through telepsychiatry in a university hospital. Rev. Nac. (Itauguá) [Internet]. 2021 Dec. 30 [cited 2024 Nov. 22];13(2):18-2. Available from: http://revistadelnacional.com.py/index.php/inicio/article/view/49
Section
Artículo Original

References

Stein DJ, Scott KM, de Jonge P, Kessler RC. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 2017;19(2):127-136. doi:10.31887/DCNS.2017.19.2/dstein.

Park SC, Kim YK. Anxiety Disorders in the DSM-5: changes, controversies, and future directions. Adv Exp Med Biol. 2020;1191:187-196. doi:10.1007/978-981-32-9705-0_12.

Kim YK. Panic Disorder: current Research and management approaches. Psychiatry Investig. 2019;16(1):1-3. doi:10.30773/pi.2019.01.08.

Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet. 2006;368(9540):1023-1032. doi:10.1016/S0140-6736(06)69418-X.

Perugi G, Frare F, Toni C. Diagnosis and treatment of agoraphobia with panic disorder. CNS Drugs. 2007;21(9):741-764. doi:10.2165/00023210-200721090-00004.

Eaton WW, Bienvenu OJ, Miloyan B. Specific phobias. Lancet Psychiatry. 2018;5(8):678-686. doi:10.1016/S2215-0366(18)30169-X.

Leichsenring F, Leweke F. Social anxiety disorder. N Engl J Med. 2017;376(23):2255-2264. doi:10.1056/NEJMcp1614701.

Parmentier H, García-Campayo J, Prieto R. Comprehensive review of generalized anxiety disorder in primary care in Europe. Curr Med Res Opin. 2013;29(4):355-367. doi:10.1185/03007995.2013.770731.

Borza L. Cognitive-behavioral therapy for generalized anxiety. Dialogues Clin Neurosci. 2017;19(2):203-208. doi:10.31887/DCNS.2017.19.2/lborza.

Lee S, Creed FH, Ma YL, Leung CM. Somatic symptom burden and health anxiety in the population and their correlates. J Psychosom Res. 2015;78(1):71-76. doi:10.1016/j.jpsychores.2014.11.012.

Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66(4):317-320. doi.:10.1177/0020764020915212.

Torales J, Ríos-González C, Barrios I, O'Higgins M, González I, García O, et al. Self-perceived stress during the quarantine of COVID-19 pandemic in Paraguay: an exploratory survey. Front Psychiatry. 2020;11:558691. doi:10.3389/fpsyt.2020.558691.

Cowan KE, McKean AJ, Gentry MT, Hilty DM. Barriers to use of telepsychiatry: clinicians as gatekeepers. Mayo Clin Proc. 2019;94(12):2510-2523. doi:10.1016/j.mayocp.2019.04.018.

Chen JA, Chung WJ, Young SK, Tuttle MC, Collins MB, Darghouth SL, et al. COVID-19 and telepsychiatry: early outpatient experiences and implications for the future. Gen Hosp Psychiatry. 2020;66:89-95. doi:10.1016/j.genhosppsych.2020.07.002.

Brunoni AR, Suen PJC, Bacchi PS, Razza LB, Klein I, Dos Santos LA, et al. Prevalence and risk factors of psychiatric symptoms and diagnoses before and during the COVID-19 pandemic: findings from the ELSA-Brasil COVID-19 mental health cohort. Psychol Med. 2021:1-12. doi:10.1017/S0033291721001719.

Ramón-Arbués E, Gea-Caballero V, Granada-López JM, Juárez-Vela R, Pellicer-García B, Antón-Solanas I. The prevalence of depression, anxiety and stress and their associated factors in college students. Int J Environ Res Public Health. 2020;17(19):7001. doi:10.3390/ijerph17197001.

Elbinoune I, Amine B, Shyen S, Gueddari S, Abouqal R, Hajjaj-Hassouni N. Chronic neck pain and anxiety-depression: prevalence and associated risk factors. Pan Afr Med J. 2016;24:89. doi:10.11604/pamj.2016.24.89.8831.

Kupfer DJ. Anxiety and DSM-5. Dialogues Clin Neurosci. 2015;17(3):245-246. doi:10.31887/DCNS.2015.17.3/dkupfer.

Talevi D, Socci V, Carai M, Carnaghi G, Faleri S, Trebbi E, et al. Mental health outcomes of the CoViD-19 pandemic. Riv Psichiatr. 2020;55(3):137-144. doi:10.1708/3382.33569.

Grazzi M, Vergara V. ICT in developing countries: Are language barriers relevant? Evidence from Paraguay 2012:24(2):161-171. doi:10.1016/j.infoecopol.2011.11.001

Hoppe LJ, Ipser J, Gorman JM, Stein DJ. Panic disorder. Handb Clin Neurol. 2012;106:363-374. doi:10.1016/B978-0-444-52002-9.00020-6.

Sivolap YP. Panic disorder: clinical phenomena and treatment options. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(4):112-116. doi:10.17116/jnevro20171174112-116.

Torales J, Barrios I, Ayala N, O’Higgins M, Palacios JM, Ríos-González C, et al. Ansiedad y depresión en relación a noticias sobre COVID-19: un estudio en población general paraguaya. Rev. salud publica Parag. 2021;11(1):67-73. doi:10.18004/rspp.2021.junio.67.

Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R, et al. Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110207. doi:10.1016/j.pnpbp.2020.110207.

Pfefferbaum B, North CS. Mental health and the Covid-19 Pandemic. N Engl J Med. 2020;383(6):510-512. doi:10.1056/NEJMp2008017

Chew NWS, Lee GKH, Tan BYQ, Jing M, Goh Y, Ngiam NJH, et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun. 2020;88:559-565. doi:10.1016/j.bbi.2020.04.049.

Villalba-Arias J, Estigarribia G, Bogado JA, Méndez J, Toledo S, González I, et al. Psychological impact of COVID-19 pandemic among healthcare workers in Paraguay: A descriptive and preliminary study. Medicina Clínica y Social. 2020;4(3):93-97. doi:10.52379/mcs.v4i3.156.

Bueno-Notivol J, Gracia-García P, Olaya B, Lasheras I, López-Antón R, Santabárbara J. Prevalence of depression during the COVID-19 outbreak: a meta-analysis of community-based studies. Int J Clin Health Psychol. 2021;21(1):100196. doi:10.1016/j.ijchp.2020.07.007.